Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
Microbiology Spectrum · 17.08.2023 · 11 (4)
DOI: 10.1128/spectrum.00465-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 17.08.2023. Verfasst von Rachel F Rollo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, DHAC | National Health and Medical Research Council, Department of Education and Training | Australian Research Council.
Abstract (Originalsprache)
Tuberculosis (TB) is an infectious disease that affects millions of people globally, with 1.6 million deaths annually. TB treatment requires combinations of multiple different antibiotics for many months, and toxic side effects can occur.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
- National and WHO Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
- Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
ORCID-Profile: Rachel F Rollo, Giorgia Mori, Timothy A Hill, Stefan Niemann, Susanne Homolka, David P Fairlie, Antje Blumenthal
Förderung
- U.S. Department of Defense
- DHAC | National Health and Medical Research Council
- Department of Education and Training | Australian Research Council
Zitieren
APA
Rollo, R. F., Mori, G., Hill, T. A., Hillemann, D., Niemann, S., Homolka, S., Fairlie, D. P., & Blumenthal, A. (2023). Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis. Microbiology Spectrum, 11(4). https://doi.org/10.1128/spectrum.00465-23
Vancouver
Rollo RF, Mori G, Hill TA, Hillemann D, Niemann S, Homolka S, et al. Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis. Microbiology Spectrum. 2023;11(4). doi:10.1128/spectrum.00465-23
BibTeX
@article{Rollo2023,
author = {Rollo, Rachel F and Mori, Giorgia and Hill, Timothy A and Hillemann, Doris and Niemann, Stefan and Homolka, Susanne and Fairlie, David P and Blumenthal, Antje},
title = {Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {4},
doi = {10.1128/spectrum.00465-23}
}
EUVIMED